| Authors: |
Nielsen SM; aLabcorp (formerly Invitae Corp.), San Francisco, CA., Russell EM; aLabcorp (formerly Invitae Corp.), San Francisco, CA., Ellsworth RE; aLabcorp (formerly Invitae Corp.), San Francisco, CA., Hughes KS; bDivision of Oncologic & Endocrine Surgery, Department of Surgery, Medical University of South Carolina, Charleston, SC., Heald B; cFormer employee of Invitae Corp., San Francisco, CA.; dExact Sciences, Madison, WI., Beitsch PD; eDallas Surgical Group, Dallas, TX., Moretz C; cFormer employee of Invitae Corp., San Francisco, CA.; fBaylor Genetics, Houston, TX., Pineda-Alvarez DE; aLabcorp (formerly Invitae Corp.), San Francisco, CA., Esplin ED; aLabcorp (formerly Invitae Corp.), San Francisco, CA., Nussbaum RL; cFormer employee of Invitae Corp., San Francisco, CA.; gDivision of Medical Genetics, Department of Pediatrics, University of San Francisco, San Francisco, CA., Facio FM; aLabcorp (formerly Invitae Corp.), San Francisco, CA., Kurian AW; hDepartments of Medicine, and Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA. |